Cross-Neutralizing CRF01-AE-Infected Plasma from Malaysia Targets CD4-Binding Site of Human Immunodeficiency Virus Type-1 Envelope Glycoprotein
Human immunodeficiency virus type-1 (HIV-1) antigenic variation poses a great challenge for vaccine immunogen design to elicit broadly neutralizing antibodies (bNAbs). Over the last 10-15 years, great progress has been made to understand the conserved sites of sensitivity on HIV envelope glycoprotei...
Saved in:
Main Authors: | Ng, Qi Ron *, Tee, Kok Keng, Binley, James M, Tong, Tommy * |
---|---|
Format: | Article |
Published: |
Mary Ann Liebert
2022
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/3022/ https://doi.org/10.1089/aid.2020.0299 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-neutralizing crf01_ae-infected plasma from Malaysia targets cd4-binding site of human immunodeficiency virus type-1 envelope glycoprotein
by: Ng, Qi Ron, et al.
Published: (2022) -
The evaluation of anti-envelope antibodies in patient plasmas infected with human immunodeficiency virus type 1 subtype CRF01_AE
by: Ng, Qi Ron
Published: (2020) -
Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 envelope glycoprotein trimers on neutralizing antibody induction
by: Crooks, Ema T, et al.
Published: (2017) -
Emergence of HIV-1 CRF01AE/B unique recombinant forms in Kuala Lumpur, Malaysia
by: Tee, K.K., et al.
Published: (2005) -
Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
by: Lau, Katherine A., et al.
Published: (2010)